SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
Datum | Rating | Analyst | |
---|---|---|---|
15.01.18 | Roche Sell | Société Générale Group S.A. (SG) | |
15.01.18 | Novartis Hold | Deutsche Bank AG | |
11.01.18 | Roche overweight | JP Morgan Chase & Co. | |
10.01.18 | Novartis Neutral | JP Morgan Chase & Co. | |
08.01.18 | Roche Neutral | UBS AG | |
05.01.18 | Roche buy | Jefferies & Company Inc. | |
29.12.17 | Roche overweight | JP Morgan Chase & Co. | |
29.12.17 | Novartis Neutral | JP Morgan Chase & Co. | |
27.12.17 | Novartis Halten | Norddeutsche Landesbank (Nord/LB) | |
27.12.17 | Roche kaufen | Norddeutsche Landesbank (Nord/LB) | |
21.12.17 | Roche overweight | Barclays Capital | |
13.12.17 | Roche overweight | JP Morgan Chase & Co. | |
12.12.17 | Roche Hold | Deutsche Bank AG | |
12.12.17 | Roche overweight | JP Morgan Chase & Co. | |
11.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
08.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
08.12.17 | Roche Equal-Weight | Morgan Stanley | |
08.12.17 | Roche Neutral | UBS AG | |
08.12.17 | Roche overweight | JP Morgan Chase & Co. | |
07.12.17 | Roche Neutral | UBS AG | |
07.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
06.12.17 | Roche Neutral | UBS AG | |
06.12.17 | Roche buy | Merrill Lynch & Co., Inc. | |
06.12.17 | Novartis Underperform | Merrill Lynch & Co., Inc. | |
01.12.17 | Roche Equal-Weight | Morgan Stanley | |
01.12.17 | Novartis overweight | Morgan Stanley | |
01.12.17 | Roche Outperform | Bernstein Research | |
21.11.17 | Roche buy | Baader Bank | |
21.11.17 | Roche Hold | Deutsche Bank AG | |
21.11.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
21.11.17 | Roche Reduce | HSBC | |
20.11.17 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
20.11.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
20.11.17 | Roche overweight | JP Morgan Chase & Co. | |
17.11.17 | Roche Equal-Weight | Morgan Stanley | |
17.11.17 | Roche Hold | Deutsche Bank AG | |
17.11.17 | Roche overweight | JP Morgan Chase & Co. | |
16.11.17 | Roche buy | Jefferies & Company Inc. | |
14.11.17 | Novartis overweight | Morgan Stanley | |
08.11.17 | Novartis Hold | Deutsche Bank AG |